European Archives - Page 22 of 1343 - European Medical Journal

Diabetic Kidney Disease Risk Linked to RAR inflammatory marker - EMJ

Novel Inflammatory-Nutritional Marker Linked to Diabetic Kidney Disease Risk

A large NHANES analysis shows the red cell distribution width-to-albumin ratio is strongly associated with diabetic kidney disease risk in adults with diabetes.

Chronic Bronchitis Overlooked in Low-Income Countries - EMJ

Chronic Bronchitis Widespread and Overlooked in Low-Income Countries

Chronic bronchitis affects nearly 10% of adults in low- and middle-income countries, with links to worse respiratory outcomes.

Door with light pouring out of it

NICE appoints Prof Jonathan Benger as new CEO

His appointment comes at a pivotal moment for the organisation, as NICE prepares to help deliver the 10 Year Health Plan for the NHS.

Pre-processing Improves AI Breast Imaging Accuracy

A study has found that the way medical images are prepared before analysis can have a significant impact on the performance of deep learning models.

Biomarker Monitoring Shows Cardioprotection in Cancer - EMJ

Study Explores Cardioprotection During Cancer Therapy

Find out more about early evidence supporting biomarker-guided cardioprotection in patients receiving anthracycline therapy.

EMJ Dermatology 13 [Supplement 4] 2025

Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that presents heterogeneously across patients. It carries a…

Value of Achieving Minimal Disease Activity in Atopic Dermatitis

Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that presents heterogeneously across patients. It carries a…

breast cancer

New Model Targets Late Relapse Risk in Common Breast Cancer Type

Researchers have developed a genomic model that could improve predictions of long-term recurrence in a common form of breast cancer.

AI Model Advances Prediabetes Prediction - EMJ

AI Model Advances Prediabetes Prediction

A highly accurate AI model improves prediabetes prediction by integrating antioxidant status with standard risk factors.

Changing Paradigms in GI Oncology

In this symposium, Ian Chau, Heinz-Josef Lenz, and Arndt Vogel shared insights on the changing paradigm across gastrointestinal (GI)…